{"id":109701,"date":"2026-08-05T09:00:00","date_gmt":"2026-08-05T07:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?p=109701"},"modified":"2026-08-03T11:41:47","modified_gmt":"2026-08-03T09:41:47","slug":"de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients","status":"publish","type":"post","link":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/","title":{"rendered":"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0"},"content":{"rendered":"<p class=\"heading-para wp-block-paragraph\"><em>\u00ab\u202fNous devons nous assurer que c\u2019est industrialisable, s\u00fbr et reproductible \u2014 afin que chaque patient re\u00e7oive le m\u00eame m\u00e9dicament \u00e0 chaque fois.\u202f\u00bb\u00a0<\/em><\/p>\n\n<p class=\"heading-para wp-block-paragraph\">En tant que responsable CMC d\u00e9di\u00e9 au d\u00e9veloppement de nouveaux actifs, Ian Fox travaille \u00e0 l\u2019interface entre la recherche et l\u2019application \u2014 transformant des mol\u00e9cules prometteuses en traitements concrets. Il d\u00e9crit son r\u00f4le comme \u00ab\u202fune sorte de passerelle entre l\u2019identification pr\u00e9coce d\u2019une cible en recherche et la mise \u00e0 disposition d\u2019un produit final durable, ma\u00eetris\u00e9, s\u00fbr et de qualit\u00e9, capable de r\u00e9pondre aux besoins des patients.\u202f\u00bb\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Ian accompagne la transition de la chimie m\u00e9dicinale vers le d\u00e9veloppement clinique, en traduisant la d\u00e9couverte en produits constants et de haute qualit\u00e9. Cela implique d\u2019\u00e9valuer tr\u00e8s t\u00f4t les proc\u00e9d\u00e9s de fabrication, afin de s\u2019assurer qu\u2019ils sont viables non seulement en th\u00e9orie, mais aussi \u00e0 l\u2019\u00e9chelle industrielle. \u00ab\u202fLa qualit\u00e9 doit \u00eatre identique \u00e0 chaque fois, la dose doit \u00eatre la m\u00eame \u2014 un m\u00e9dicament parfait \u00e0 chaque administration\u202f\u00bb, explique-t-il.\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Ian n\u2019a pas commenc\u00e9 sa carri\u00e8re dans le d\u00e9veloppement. Son parcours a d\u00e9but\u00e9 dans la production industrielle, puis il a souhait\u00e9 se rapprocher impact direct. \u00ab\u202fPasser au d\u00e9veloppement pharmaceutique m\u2019offre la possibilit\u00e9 d\u2019atteindre davantage de patients et de changer leur vie.\u202f\u00bb\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Cette \u00e9volution a n\u00e9cessit\u00e9 une progression personnelle. Il a \u00ab\u202fgravi les \u00e9chelons\u202f\u00bb et obtenu un master ax\u00e9 sur les proc\u00e9d\u00e9s de fabrication innovants. La structure d\u2019Ipsen lui a permis de changer d\u2019\u00e9quipe, d\u2019\u00e9largir son expertise technique et d\u2019occuper un poste o\u00f9 la science est directement reli\u00e9e aux patients.\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Il est convaincu que l\u2019avenir repose sur de meilleurs outils et une collaboration renforc\u00e9e. \u00ab\u202fGr\u00e2ce aux avanc\u00e9es de l\u2019IA, nous pourrions r\u00e9duire les risques ou le niveau de tests \u00e0 r\u00e9aliser \u2014 gr\u00e2ce \u00e0 une mod\u00e9lisation plus efficace\u202f\u00bb, explique-t-il. \u00ab\u202fDes outils comme ceux-ci aideront les scientifiques et nous permettront de nous concentrer davantage sur le c\u0153ur de notre travail.\u202f\u00bb\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Au final, pour Ian, tout repose sur la collaboration. \u00ab\u202fSans collaboration, le produit n\u2019arrive pas sur le march\u00e9. En travaillant ensemble, nous garantissons les m\u00eames r\u00e9sultats pour chaque patient, \u00e0 chaque fois.\u202f\u00bb\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00ab\u202fNous devons nous assurer que c\u2019est industrialisable, s\u00fbr et reproductible \u2014 afin que chaque patient re\u00e7oive le m\u00eame m\u00e9dicament \u00e0<\/p>\n","protected":false},"author":11,"featured_media":109698,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[81827],"tags":[],"class_list":["post-109701","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science-2","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0 - Global<\/title>\n<meta name=\"description\" content=\"En tant que responsable CMC d\u00e9di\u00e9 au d\u00e9veloppement de nouveaux actifs, Ian Fox travaille \u00e0 l\u2019interface entre la recherche et l\u2019application \u2014 transformant des mol\u00e9cules prometteuses en traitements concrets. Il d\u00e9crit son r\u00f4le comme \u00ab\u202fune sorte de passerelle entre l\u2019identification pr\u00e9coce d\u2019une cible en recherche et la mise \u00e0 disposition d\u2019un produit final durable, ma\u00eetris\u00e9, s\u00fbr et de qualit\u00e9, capable de r\u00e9pondre aux besoins des patients.\u202f\u00bb\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0 - Global\" \/>\n<meta property=\"og:description\" content=\"En tant que responsable CMC d\u00e9di\u00e9 au d\u00e9veloppement de nouveaux actifs, Ian Fox travaille \u00e0 l\u2019interface entre la recherche et l\u2019application \u2014 transformant des mol\u00e9cules prometteuses en traitements concrets. Il d\u00e9crit son r\u00f4le comme \u00ab\u202fune sorte de passerelle entre l\u2019identification pr\u00e9coce d\u2019une cible en recherche et la mise \u00e0 disposition d\u2019un produit final durable, ma\u00eetris\u00e9, s\u00fbr et de qualit\u00e9, capable de r\u00e9pondre aux besoins des patients.\u202f\u00bb\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-05T07:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/08\/Guess-Our-Ian-Website.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1082\" \/>\n\t<meta property=\"og:image:height\" content=\"620\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"heloisedetouchet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"heloisedetouchet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/\"},\"author\":{\"name\":\"heloisedetouchet\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/person\\\/2c275168b31beee81688f3c041877318\"},\"headline\":\"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0\",\"datePublished\":\"2026-08-05T07:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/\"},\"wordCount\":408,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Guess-Our-Ian-Website.png\",\"articleSection\":[\"Science\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/\",\"name\":\"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0 - Global\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Guess-Our-Ian-Website.png\",\"datePublished\":\"2026-08-05T07:00:00+00:00\",\"description\":\"En tant que responsable CMC d\u00e9di\u00e9 au d\u00e9veloppement de nouveaux actifs, Ian Fox travaille \u00e0 l\u2019interface entre la recherche et l\u2019application \u2014 transformant des mol\u00e9cules prometteuses en traitements concrets. Il d\u00e9crit son r\u00f4le comme \u00ab\u202fune sorte de passerelle entre l\u2019identification pr\u00e9coce d\u2019une cible en recherche et la mise \u00e0 disposition d\u2019un produit final durable, ma\u00eetris\u00e9, s\u00fbr et de qualit\u00e9, capable de r\u00e9pondre aux besoins des patients.\u202f\u00bb\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Guess-Our-Ian-Website.png\",\"contentUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Guess-Our-Ian-Website.png\",\"width\":1082,\"height\":620},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Ipsengroup\",\"https:\\\/\\\/x.com\\\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/person\\\/2c275168b31beee81688f3c041877318\",\"name\":\"heloisedetouchet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"caption\":\"heloisedetouchet\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0 - Global","description":"En tant que responsable CMC d\u00e9di\u00e9 au d\u00e9veloppement de nouveaux actifs, Ian Fox travaille \u00e0 l\u2019interface entre la recherche et l\u2019application \u2014 transformant des mol\u00e9cules prometteuses en traitements concrets. Il d\u00e9crit son r\u00f4le comme \u00ab\u202fune sorte de passerelle entre l\u2019identification pr\u00e9coce d\u2019une cible en recherche et la mise \u00e0 disposition d\u2019un produit final durable, ma\u00eetris\u00e9, s\u00fbr et de qualit\u00e9, capable de r\u00e9pondre aux besoins des patients.\u202f\u00bb\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/","og_locale":"fr_FR","og_type":"article","og_title":"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0 - Global","og_description":"En tant que responsable CMC d\u00e9di\u00e9 au d\u00e9veloppement de nouveaux actifs, Ian Fox travaille \u00e0 l\u2019interface entre la recherche et l\u2019application \u2014 transformant des mol\u00e9cules prometteuses en traitements concrets. Il d\u00e9crit son r\u00f4le comme \u00ab\u202fune sorte de passerelle entre l\u2019identification pr\u00e9coce d\u2019une cible en recherche et la mise \u00e0 disposition d\u2019un produit final durable, ma\u00eetris\u00e9, s\u00fbr et de qualit\u00e9, capable de r\u00e9pondre aux besoins des patients.\u202f\u00bb\u00a0","og_url":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/","og_site_name":"Global","article_published_time":"2026-08-05T07:00:00+00:00","og_image":[{"width":1082,"height":620,"url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/08\/Guess-Our-Ian-Website.png","type":"image\/png"}],"author":"heloisedetouchet","twitter_card":"summary_large_image","twitter_creator":"@ipsengroup","twitter_site":"@ipsengroup","twitter_misc":{"Written by":"heloisedetouchet","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/"},"author":{"name":"heloisedetouchet","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/2c275168b31beee81688f3c041877318"},"headline":"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0","datePublished":"2026-08-05T07:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/"},"wordCount":408,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/08\/Guess-Our-Ian-Website.png","articleSection":["Science"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/","url":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/","name":"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0 - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/08\/Guess-Our-Ian-Website.png","datePublished":"2026-08-05T07:00:00+00:00","description":"En tant que responsable CMC d\u00e9di\u00e9 au d\u00e9veloppement de nouveaux actifs, Ian Fox travaille \u00e0 l\u2019interface entre la recherche et l\u2019application \u2014 transformant des mol\u00e9cules prometteuses en traitements concrets. Il d\u00e9crit son r\u00f4le comme \u00ab\u202fune sorte de passerelle entre l\u2019identification pr\u00e9coce d\u2019une cible en recherche et la mise \u00e0 disposition d\u2019un produit final durable, ma\u00eetris\u00e9, s\u00fbr et de qualit\u00e9, capable de r\u00e9pondre aux besoins des patients.\u202f\u00bb\u00a0","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/#primaryimage","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/08\/Guess-Our-Ian-Website.png","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/08\/Guess-Our-Ian-Website.png","width":1082,"height":620},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/de-la-molecule-au-medicament-les-etapes-vers-des-traitements-prets-pour-les-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"De la mol\u00e9cule au m\u00e9dicament : les \u00e9tapes vers des traitements pr\u00eats pour les patients\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/2c275168b31beee81688f3c041877318","name":"heloisedetouchet","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","caption":"heloisedetouchet"}}]}},"jetpack_featured_media_url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/08\/Guess-Our-Ian-Website.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/109701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/comments?post=109701"}],"version-history":[{"count":1,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/109701\/revisions"}],"predecessor-version":[{"id":109702,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/109701\/revisions\/109702"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/109698"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=109701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=109701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=109701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}